Spearman’s rho correlation coefficient (95 % CI) | |||
---|---|---|---|
LNV index | LNCW index | LNPD index | |
Autoimmune status | |||
IgG ACPA (U/ml)a |
−0.07 (−0.38 to 0.25) p = 0.677 |
−0.16 (−0.45 to 0.16) p = 0.321 |
−0.04 (−0.35 to 0.27) p = 0.790 |
(ACPA-positive patients) |
0.04 (−0.41 to 0.47) p = 0.874 |
−0.20 (−0.59 to 0.27) p = 0.402 |
−0.12 (−0.54 to 0.34) p = 0.605 |
IgM RF (U/ml) |
−0.01 (−0.33 to 0.30) p = 0.936 |
0.05 (−0.27 to 0.36) p = 0.752 |
0.09 (−0.23 to 0.40) p = 0.568 |
(RF-positive patients) |
0.08 (−0.40 to 0.52) p = 0.760 |
0.20 (−0.29 to 0.61) p = 0.414 |
0.23 (−0.27 to 0.63) p = 0.361 |
Joint assessment—clinical | |||
TJC28 |
0.01 (−0.30 to 0.33) p = 0.945 |
0.01 (−0.30 to 0.33) p = 0.929 |
−0.02 (−0.33 to 0.30) p = 0.910 |
TJC (ipsilateral)b, c |
−0.02 (−0.34 to 0.29) p = 0.876 |
0.00 (−0.32 to 0.31) p = 0.994 |
−0.07 (−0.38 to 0.25) p = 0.656 |
SJC28 |
0.14 (−0.18 to 0.44) p = 0.394 |
0.24 (−0.08 to 0.52) p = 0.142 |
0.24 (−0.08 to 0.51) p = 0.147 |
SJC (ipsilateral)b, c |
0.15 (−0.17 to 0.44) p = 0.366 |
0.25 (−0.07 to 0.53) p = 0.121 |
0.21 (−0.11 to 0.50) p = 0.189 |
Joint assessment—PDUS | |||
12-joint GS index |
0.30 (−0.02 to 0.56) p = 0.063 |
0.33 (0.02–0.59) p = 0.039 |
0.36 (0.05–0.60) p = 0.026 |
GS index (ipsilateral)b |
0.15 (−0.17 to 0.45) p = 0.347 |
0.39 (0.08–0.62) p = 0.015 |
0.25 (−0.06 to 0.53) p = 0.117 |
GS index (contralateral) |
0.05 (−0.27 to 0.36) p = 0.767 |
0.21 (−0.11 to 0.49) p = 0.204 |
0.14 (−0.18 to 0.44) p = 0.392 |
12-joint PD index |
0.46 (0.17–0.68) p = 0.003 |
0.31 (0.00–0.57) p = 0.053 |
0.35 (0.04–0.60) p = 0.029 |
PD index (ipsilateral)b |
0.40 (0.10–0.64) p = 0.011 |
0.42 (0.12–0.65) p = 0.007 |
0.36 (0.05–0.61) p = 0.024 |
PD index (contralateral) |
0.16 (−0.17 to 0.45) p = 0.340 |
0.16 (−0.17 to 0.45) p = 0.342 |
0.19 (−0.13 to 0.48) p = 0.235 |